Mojsov’s discovery of GLP-1 and its critical role in the regulation of insulin secretion and blood glucose led to the development of a revolutionary new class of medicines.

The Association for the Accreditation of Human Research Protection Programs once again commended Rockefeller’s standards and practices.  

A treatment that appears effective in cancers such as myelofibrosis consistently fails in breast cancer clinical trials. A new study explains why.

New study demonstrates that one type of lipid is so critical for immune evasion that certain cancers cannot proliferate without them. Modulating intake of dietary lipids could open up an avenue for treatment.

The study explains why treatments for many autoimmune and inflammatory diseases raise the risk of contracting TB—and also upends long-held assumptions about what kicks off an immune response.      

Researchers created a tool capable of comprehensively mapping crucial interactions underlying drug efficacy in one superfamily of cell receptors.

Findings bolster the idea that the functions of this protein—MeCP2—are more centered on nucleosomes, rather than other forms of DNA.

CDCA7, whose mutations alter DNA methylation pattern and cause immunodeficiency, is a novel sensor for a special class of methylated DNA.

A tandem signaling process turns ordinary cells into an efficient cleanup crew.

A Rockefeller employee since 2001, Chin will be missed by many in the community who came to rely on his deep technical expertise and graceful approach to problem solving.

Hyperactivity, repetitive behavior, and language deficits all appeared in the mice, highlighting an unexpected role the cerebellum seems to play in autism.

Rockefeller University Hospital developed a model clinical infrastructure for the study, as well as helped conduct it.

An ambitious study inspired a transformational renovation.

Researchers found a “neuro-cancer axis”  that may promote the spread of breast cancer. They also found that an FDA-approved anti-nausea medication may prevent it.

Students in the BIOGROW program participate in professional development and community building events in collaboration with the university's Office of Diversity, Equity, and Inclusion.

Every summer, Rockefeller postdocs and students take to the stage to share their latest research.

Victora, who studies how antibodies are generated in response to infection and immunization, is among 26 scientists nationwide to receive this designation.

Four community members—Sadye Paez, Elizabeth Campbell, Yuriria Vázquez, and Chad Morton—were recognized for their advocacy work both within the university and in the wider scientific community.

A novel platform for identifying metabolic gene functions has already revealed interactions between proteins and metabolites that are fundamental to cell metabolism.

Parthenogenic species must compensate for their limited gene pool or risk extinction.

President Lifton hosted a community celebration of Wiesel, a Nobel laureate as well as former university president.

New tech reveals findings that address long-standing theories about how bacteria begin the process of making RNA from DNA.

The infectious disease specialist will continue her groundbreaking work on the transcriptomes of the pathogens behind tuberculosis and Covid.

Vosshall is recognized for her pioneering studies of the mosquito Aedes aegypti, which transmits pathogens causing human diseases including dengue, Zika, chikungunya, and yellow fever.

With a new microscope that's as light as a penny, researchers can now observe broad swaths of the brain in action as mice move about and interact with their environments.

An unexpected discovery may pave the way to better treatments for a broad range of cancers.

Since first detected in birds in 2021, avian flu has killed millions of poultry and infected animals once thought to be immune. What early warning signs could point to an increasing risk for humans?

The researcher is being honored for his discovery of a specialized system in the brain’s neocortex that is responsible for recognizing faces.

Nobel laureate Frances H. Arnold, STEM advocate Freeman A. Hrabowski, III, and climatologist Michael E. Mann also received honorary degrees.